首页> 美国卫生研究院文献>American Journal of Human Genetics >Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
【2h】

Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.

机译:晚期婴儿和成年GM2神经节病患者以及低己糖胺酶水平的健康先证者的培养成纤维细胞中神经节苷脂GM2 N-乙酰基-β-D-半乳糖苷酶活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A sensitive assay was developed to assess the ability of extracts from cultured fibroblasts to catabolize ganglioside GM2, in the presence of the natural activator protein but without detergents. This method, which permitted the reliable determination of residual activities as low as 0.1% of normal controls, was then used to measure ganglioside GM2 hydrolase activities in fibroblasts from several hexosaminidase variants. The residual activities thus determined correlated well with the clinical status of the respective proband: infantile Tay-Sachs (0.1% of normal controls), late-infantile (0.5%), and adult GM2 gangliosidoses (2%-4%) and healthy probands with "low hexosaminidase" (11% and 20%). In contrast, beta-hexosaminidase A levels as measured with the synthetic substrate 4-MU-GlcNAc could not be relied on for diagnostic purposes (the late-infantile patient studied retained 80% of the activity of controls).
机译:开发了一种灵敏的检测方法,用于评估在天然活化蛋白存在但不含去污剂的情况下,培养的成纤维细胞提取物分解神经节苷脂GM2的能力。该方法可可靠地测定低至正常对照的0.1%的残留活性,然后用于测量来自几种己糖胺酶变体的成纤维细胞中神经节苷脂GM2水解酶的活性。因此确定的残留活性与相应先证者的临床状况密切相关:婴儿Tay-Sachs(正常对照组的0.1%),晚期婴儿(0.5%)和成人GM2神经节苷脂病(2%-4%)和健康先证者具有“低己糖胺酶”(11%和20%)。相反,以合成底物4-MU-GlcNAc测得的β-己糖胺酶A水平不能用于诊断目的(研究的晚期婴儿患者保留了80%的对照活性)。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号